FDD-based startup cost, franchise fee, revenue, profit, SBA default rate, and investment risk signals for AmerisourceBergen Drug using its latest 2026 FDD coverage.
Based on 2026 FDD · 6 filings in corpus · Latest FDD: 2026
Cost and profit at a glance
Based on FDDIQ's FDD corpus, a AmerisourceBergen Drug franchise shows an estimated initial investment of $44K – $575K. The franchisor does not provide enough Item 19 data for a clean profit estimate. Use the links below to compare the cost, revenue, SBA loan history, and ROI against other franchises before you request the full FDD.
Quick fee read: Fees not disclosed. These figures are directional screening data, not a substitute for reading the current FDD and speaking with existing operators.
Estimated using sector-average margins. Actual franchise economics vary by location, operator, and market conditions.
Industry averages based on FranchiseIQ corpus benchmarks. ▲ = better than avg, ▼ = worse.
Weight-loss drugs are changing consumer behavior. Franchise buyers should think beyond restaurant...
FDD Item 7 breaks down every cost category required to open a franchise - from the franchise fee ...
SBA 7(a) franchise loan approval rates by brand, default rates by sector, and what lenders look f...
Compare every franchise financing option - SBA 7(a) loans, SBA 504 loans, ROBS (401k rollovers), ...
Everything you need to know about SBA 7(a) franchise loans - eligibility, the SBA Franchise Direc...
5 data-driven questions every AmerisourceBergen Drug franchise buyer should ask.